Sign up to save your podcasts
Or
Share DEBATE: If gene therapy for hemophilia B were available in Canada tomorrow, would you want to receive it?
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
DEBATE: If gene therapy for hemophilia B were available in Canada tomorrow, would you want to receive it?
In this podcast, Elizabeth Vansant, Mark Pervan, Murray Milne and Mathieu Jackson, all individuals with severe hemophilia B, are asked to debate the question: “If gene therapy for hemophilia B were available in Canada tomorrow, would you want to receive it?”
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
View all episodes
By Canadian Hemophilia SocietyIn this podcast, Elizabeth Vansant, Mark Pervan, Murray Milne and Mathieu Jackson, all individuals with severe hemophilia B, are asked to debate the question: “If gene therapy for hemophilia B were available in Canada tomorrow, would you want to receive it?”
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.